Carillon Tower Advisers’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $17.7M | Sell |
194,343
-18,897
| -9% | -$1.72M | 0.11% | 267 |
|
|
2020
Q3 | $17M | Sell |
213,240
-8,835
| -4% | -$705K | 0.23% | 170 |
|
|
2020
Q2 | $15.3M | Hold |
222,075
| – | – | 0.12% | 243 |
|
|
2020
Q1 | $14M | Sell |
222,075
-32,175
| -13% | -$2.02M | 0.14% | 227 |
|
|
2019
Q4 | $19.8M | Buy |
254,250
+58,950
| +30% | +$4.58M | 0.13% | 259 |
|
|
2019
Q3 | $14.3M | Sell |
195,300
-1,254,777
| -87% | -$92M | 0.1% | 291 |
|
|
2019
Q2 | $89.3M | Sell |
1,450,077
-47,400
| -3% | -$2.92M | 0.61% | 26 |
|
|
2019
Q1 | $95.5M | Buy |
1,497,477
+127,125
| +9% | +$8.11M | 0.68% | 19 |
|
|
2018
Q4 | $70M | Sell |
1,370,352
-199,245
| -13% | -$10.2M | 0.59% | 34 |
|
|
2018
Q3 | $91.1M | Sell |
1,569,597
-92,850
| -6% | -$5.39M | 0.65% | 24 |
|
|
2018
Q2 | $80.7M | Buy |
1,662,447
+547,806
| +49% | +$26.6M | 0.64% | 23 |
|
|
2018
Q1 | $50.3M | Buy |
1,114,641
+121,809
| +12% | +$5.5M | 0.39% | 75 |
|
|
2017
Q4 | $37.3K | Buy |
+992,832
| New | +$37.3K | 0.4% | 90 |
|